TipHub

1,744.4

+26.12 +1.52%

29 Jul 2026

NSE Listed · Chemicals

LT-ASM · ASM 1 · ST-ASM · ASM 1
What does LT-ASM · ASM 1 · ST-ASM · ASM 1 mean?
BSE · Long Term Additional Surveillance Measure (ASM 1)LT-ASM is the joint SEBI/exchange framework for SUSTAINED abnormal price moves (contrast ST-ASM's 5–15-day spikes). Entry is beta-adjusted price variation versus the Nifty (e.g. 3-month high-low above 150% plus the stock's β × index move) along with client-concentration checks. Stages I–IV escalate from a 5% price band through 100% margin to Trade-for-Trade with an additional surveillance deposit. Practical meaning: the exchange still considers the price action abnormal — tighter bands and elevated margins continue even if another measure (like ESM) has lifted. A stock can sit under LT-ASM on both exchanges via either exchange's shortlisting; it is a preventive cost-of-speculation measure, not an adverse finding against the company.Criteria: High 3-month / 12-month high-low price variation, close-to-close price variation, client concentration, number of price-band hits, market-wide position limit and P/E — applied in graded Stages I–IV with escalating margin and price-band curbs.Exchange notice · 2026-07-29
NSE · Long Term Additional Surveillance Measure (ASM 1)LT-ASM is the joint SEBI/exchange framework for SUSTAINED abnormal price moves (contrast ST-ASM's 5–15-day spikes). Entry is beta-adjusted price variation versus the Nifty (e.g. 3-month high-low above 150% plus the stock's β × index move) along with client-concentration checks. Stages I–IV escalate from a 5% price band through 100% margin to Trade-for-Trade with an additional surveillance deposit. Practical meaning: the exchange still considers the price action abnormal — tighter bands and elevated margins continue even if another measure (like ESM) has lifted. A stock can sit under LT-ASM on both exchanges via either exchange's shortlisting; it is a preventive cost-of-speculation measure, not an adverse finding against the company.Criteria: High 3-month / 12-month high-low price variation, close-to-close price variation, client concentration, number of price-band hits, market-wide position limit and P/E — applied in graded Stages I–IV with escalating margin and price-band curbs.Exchange notice · 2026-07-29
BSE · Short Term Additional Surveillance Measure (ASM 1)ST-ASM catches short bursts: a beta-adjusted close-to-close move beyond ±25% in 5 trading days (or ±40% in 15) combined with concentrated trading — or a 75%+ monthly range with fewer than 100–200 unique traders. Practical meaning: margins jump to 50–100% for a few weeks to cool a spike; it either lapses quickly or escalates into LT-ASM if the move sustains.Criteria: Short-term (5 / 15 / 30-day) price-volume abnormality — high-low and close-to-close price variation over the window. Adds 100% margin and a 5% (then 2%) price band.Exchange notice · 2026-07-22

Tatva Chintan Pharma Chem Ltd. (TATVA)

Volume: 85,006Avg Vol 1W: 1,94,050Avg Vol 1M: 3,28,04752W Range:976.41,835
Key Ratios
Checked 1h ago
Market Cap₹4,081 Cr
Current Price₹1,744.4
Previous Close₹1,718.28
High / Low (52w)₹1,835 / ₹976.4
Volume85,006
Avg Vol (1W)1,94,050
Avg Vol (1M)3,28,047
Stock P/E77.91
Book Value₹334.2
Dividend Yield12%
ROE5.38%
ROA5.12%
Revenue (TTM)
Revenue Growth-2.74%
Profit Margin9.24%
Total Debt₹0 Cr
Shares Outstanding2 Cr
Face Value₹10
EPS (TTM)₹22.39
P/B5.22
Debt / Equity0.03
50 DMA₹1,302.92
200 DMA₹1,293.07
Day change+1.52%
SurveillanceLT-ASM · ASM 1 · ST-ASM · ASM 1
Price Chart
1,744.4 52.38% · 1Y
180084033.2L
2025-07-29
2026-07-29

20-day avg volume: 3.6L shares

Pros
  • Pays a dividend yield of 12.0%.
  • Company is almost debt-free.
  • Revenue grew 11% YoY.
  • Net profit is growing year over year.
Cons
  • Stock trades at a high P/E of 78.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹83 Cr₹86 Cr₹108 Cr₹117 Cr₹124 Cr₹131 Cr₹134 Cr₹167 Cr
EBITDA₹-1 Cr₹0 Cr₹2 Cr₹10 Cr₹14 Cr₹18 Cr₹18 Cr₹25 Cr
Net Profit₹-1 Cr₹0 Cr₹1 Cr₹7 Cr₹10 Cr₹15 Cr₹10 Cr₹16 Cr
EPS
Profit & Loss (Annual)
MetricDec 2024Mar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹84 Cr₹108 Cr₹385 Cr₹109 Cr₹116 Cr₹139 Cr₹133 Cr₹147 Cr
EBITDA₹-1 Cr₹2 Cr₹9 Cr₹7 Cr₹13 Cr₹19 Cr₹16 Cr₹17 Cr
Net Profit₹-1 Cr₹1 Cr₹6 Cr₹5 Cr₹9 Cr₹16 Cr₹9 Cr₹10 Cr
EPS2.44
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹188 Cr₹249 Cr₹315 Cr₹658 Cr₹759 Cr₹819 Cr₹836 Cr
Total Liabilities₹108 Cr₹131 Cr₹149 Cr₹185 Cr₹244 Cr₹82 Cr₹97 Cr
Equity₹80 Cr₹118 Cr₹166 Cr₹473 Cr₹515 Cr₹737 Cr₹739 Cr
Total Debt
Cash Flow
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹13 Cr₹34 Cr₹30 Cr₹39 Cr₹37 Cr₹107 Cr₹29 Cr
Investing₹-17 Cr₹-40 Cr₹-21 Cr₹-197 Cr₹-101 Cr₹-121 Cr₹-65 Cr
Financing₹17 Cr₹10 Cr₹-5 Cr₹235 Cr₹38 Cr₹31 Cr₹17 Cr
Free Cash Flow₹13 Cr₹34 Cr₹30 Cr₹39 Cr₹37 Cr₹107 Cr₹29 Cr
Shareholding
Promoter 72.02% Institutions 7.04% Public 20.94%
Efficiency & Working Capital
ROCE6.6%
Interest Coverage6
Dividend Payout
Debtor Days79 d
Inventory Days128 d
Payable Days31 d
Cash Conversion Cycle175 d
Working Capital Days206 d
Shareholding Details

As of 2026-06-30

Promoter72%
FII3.9%
DII3.1%
Institutions7%
Public20.9%
Promoter Pledge0%
No. of Shareholders64,921
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters72%72%72%72%72%72%72%72%72%72%72%72%
FIIs4.4%4.2%3.6%3.4%3.3%3.4%3.3%3.3%3.4%4.2%3.8%3.9%
DIIs13.8%13.1%12.8%10.6%6.8%6.3%5.5%5.1%3.9%3.3%3%3.1%
Public9.8%10.7%11.5%14%17.8%18.3%19.2%19.6%20.7%20.5%21.2%20.9%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders74,62874,51973,73073,91279,62379,00978,39376,79273,33168,65766,84264,921
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503
Major Shareholders (>1%)
NameCategoryStakeShares
Shekhar Rasiklal SomaniShareholding of Promoter and Promoter Group23.1%53,96,861
Chintan Nitinkumar ShahShareholding of Promoter and Promoter Group20.9%48,97,219
Ajay Mansukhlal PatelShareholding of Promoter and Promoter Group20.2%47,15,345
Priti Ajay PatelShareholding of Promoter and Promoter Group3.9%9,00,000
Goldman Sachs Funds - Goldman Sachs India Equity PortfolioPublic Shareholding2.6%6,06,662
Nippon Life India Trustee Ltd-a/c Nippon India Elss Tax Saver FundPublic Shareholding2.2%5,16,700
Mukul Mahavir AgrawalPublic Shareholding2.1%5,00,000
Chintan N Shah (huf)Shareholding of Promoter and Promoter Group1.9%4,47,500
Shital Chintan ShahShareholding of Promoter and Promoter Group1%2,31,000
Kajalben Shekharkumar SomaniShareholding of Promoter and Promoter Group0.9%2,18,080
Darshana Nitinkumar ShahShareholding of Promoter and Promoter Group0.2%39,628
Shitalbhai Rasiklal SomaniShareholding of Promoter and Promoter Group0%843
Somani Samir RasiklalShareholding of Promoter and Promoter Group0%482
Anushka Chintan ShahShareholding of Promoter and Promoter Group0%0
Archana Chandravadan ShahShareholding of Promoter and Promoter Group0%5
Aryan Shekhar SomaniShareholding of Promoter and Promoter Group0%0
Bharti Kirit ShahShareholding of Promoter and Promoter Group0%0
Dharmeshkumar Mansukhlal PatelShareholding of Promoter and Promoter Group0%0
Dipali Nitinkumar MehtaShareholding of Promoter and Promoter Group0%0
Ishani Ajay PatelShareholding of Promoter and Promoter Group0%0
Kabir Ajay PatelShareholding of Promoter and Promoter Group0%0
Kirit Harilal ShahShareholding of Promoter and Promoter Group0%100
Manisha Abhijit ZaveriShareholding of Promoter and Promoter Group0%0
Nehal Brijesh ShahShareholding of Promoter and Promoter Group0%0
Preyash Yashvantlal PotlaShareholding of Promoter and Promoter Group0%0
Board of Directors
NameDesignationYear
Chintan Nitinkumar ShahChairman / Executive Director / M D / Promoter2025
Ajaykumar Mansukhlal PatelWTD & Executive Director2025
Shekhar Rasiklal SomaniWTD & Executive Director2025
Subhash PatelIndependent Non Exe. Director2025
Avani Rajesh UmattIndependent Non Exe. Director2025
Manher Chinmanlal DesaiIndependent Non Exe. Director2025
Ishwar NayiCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Specialty Chemical Business₹0 Cr
Segments — Geography
RegionRevenueShare
Overseas₹219 Cr60.3%
Domestic₹144 Cr39.7%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10402323
Corporate Actions
TypeDateValueRemark
forthcoming2026-07-17Board Meetings
dividend2025-09-12₹1 (10%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025970090106
2025000909
202597000097
Insider / Designated-Person Trades

2 recent disclosure(s)

Ajay Mansukhlal PatelAcquisition · 7,15,345
Ajay Mansukhlal Patel HUFDisposal · 7,15,345
Substantial Acquisitions (SAST)

4 disclosure(s)

-06/02/2026 · 7,15,345
Dissolution Of Huf06/02/2026 · 7,15,345
Dissolution Of Huf06/02/2026 · 7,15,345
NULL06/02/2026 · 7,15,345
Company Information
Incorporated1996
ChairmanChintan Nitinkumar Shah
AuditorNDJ & Co
Investor Email[email protected]
🌐 www.tatvachintan.com

📍 No 502/17 GIDC Estate, Ankleshwar, Bharuch, Gujarat, 393002

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search